ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Approximately 90% of limited-stage Hodgkin lymphoma (HL) patients are projected to be cured with standard therapy, but many do not live their expected life span because of late treatment–related complications. New treatment paradigms are needed to reduce the use of radiation therapy (RT) as well as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Park, Steven I., Shea, Thomas C., Olajide, Oludamilola, Reddy, Nishitha M., Budde, Lihua E., Ghosh, Nilanjan, Deal, Allison M., Noe, Jeanne F., Ansell, Stephen M.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284091/
https://ncbi.nlm.nih.gov/pubmed/32516414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001871
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares